- Filed
- Nov 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 30, 2025 | 1.63B sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 1.64B sh |
| Shares Diluted | Q3 2025 · Sep 27, 2025 | 1.63B sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 1.64B sh |
| Shares Diluted | Q3 2025 · Sep 28, 2024 | 1.64B sh |
| Stock Repurchased | Q3 2025 · Sep 27, 2025 | $1.32B |
| Stock Repurchased | Q3 2025 · Sep 28, 2024 | $606M |
| Capex | Q3 2025 · Sep 27, 2025 | $752M |
| Capex | Q3 2025 · Sep 28, 2024 | $428M |
| Operating Cash Flow | Q3 2025 · Sep 27, 2025 | $5.11B |
| Operating Cash Flow | Q3 2025 · Sep 28, 2024 | $1.74B |
| Long Term Debt | Q3 2025 · Sep 27, 2025 | $2.35B |
| Long Term Debt | Q3 2025 · Dec 28, 2024 | $1.72B |
| Short Term Investments | Q3 2025 · Sep 27, 2025 | $2.44B |
| Short Term Investments | Q3 2025 · Dec 28, 2024 | $1.35B |
| Cash And Equivalents | Q3 2025 · Sep 27, 2025 | $4.81B |
| Cash And Equivalents | Q3 2025 · Dec 28, 2024 | $3.79B |
| Stockholders Equity | Q3 2025 · Sep 27, 2025 | $60.79B |
| Stockholders Equity | Q3 2025 · Dec 28, 2024 | $57.57B |
| Stockholders Equity | Q3 2025 · Sep 28, 2024 | $56.99B |
| Current Liabilities | Q3 2025 · Sep 27, 2025 | $11.7B |
| Current Liabilities | Q3 2025 · Dec 28, 2024 | $7.28B |
| Current Assets | Q3 2025 · Sep 27, 2025 | $27B |
| Current Assets | Q3 2025 · Dec 28, 2024 | $19.05B |
| Total Assets | Q3 2025 · Sep 27, 2025 | $76.89B |
| Total Assets | Q3 2025 · Dec 28, 2024 | $69.23B |
| Eps Diluted | Q3 2025 · Sep 27, 2025 | $0.75 |
| Eps Diluted | Q3 2025 · Sep 27, 2025 | $1.73 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | $0.47 |
| Eps Diluted | Q3 2025 · Sep 28, 2024 | $0.71 |
| Eps Basic | Q3 2025 · Sep 27, 2025 | $0.76 |
| Eps Basic | Q3 2025 · Sep 27, 2025 | $1.74 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | $0.48 |
| Eps Basic | Q3 2025 · Sep 28, 2024 | $0.72 |
| Sga Expense | Q3 2025 · Sep 27, 2025 | $1.07B |
| Sga Expense | Q3 2025 · Sep 27, 2025 | $2.95B |
| Sga Expense restated | Q3 2025 · Sep 28, 2024 | $707M |
| Sga Expense restated | Q3 2025 · Sep 28, 2024 | $1.95B |
| Rd Expense | Q3 2025 · Sep 27, 2025 | $2.14B |
| Rd Expense | Q3 2025 · Sep 27, 2025 | $5.76B |
| Rd Expense | Q3 2025 · Sep 28, 2024 | $1.64B |
| Rd Expense | Q3 2025 · Sep 28, 2024 | $4.74B |
| Net Income | Q3 2025 · Sep 27, 2025 | $1.24B |
| Net Income | Q3 2025 · Sep 27, 2025 | $2.82B |
| Net Income | Q3 2025 · Sep 28, 2024 | $771M |
| Net Income | Q3 2025 · Sep 28, 2024 | $1.16B |
| Operating Income | Q3 2025 · Sep 27, 2025 | $1.27B |
| Operating Income | Q3 2025 · Sep 27, 2025 | $1.94B |
| Operating Income | Q3 2025 · Sep 28, 2024 | $724M |
| Operating Income | Q3 2025 · Sep 28, 2024 | $1.03B |
| Gross Profit | Q3 2025 · Sep 27, 2025 | $4.78B |
| Gross Profit | Q3 2025 · Sep 27, 2025 | $11.58B |
| Gross Profit | Q3 2025 · Sep 28, 2024 | $3.42B |
| Gross Profit | Q3 2025 · Sep 28, 2024 | $8.84B |
| Cost Of Revenue | Q3 2025 · Sep 27, 2025 | $4.47B |
| Cost Of Revenue | Q3 2025 · Sep 27, 2025 | $12.79B |
| Cost Of Revenue | Q3 2025 · Sep 28, 2024 | $3.4B |
| Cost Of Revenue | Q3 2025 · Sep 28, 2024 | $9.28B |
| Revenue | Q3 2025 · Sep 27, 2025 | $9.25B |
| Revenue | Q3 2025 · Sep 27, 2025 | $24.37B |
| Revenue | Q3 2025 · Sep 28, 2024 | $6.82B |
| Revenue | Q3 2025 · Sep 28, 2024 | $18.13B |